AAM Wins Bronze Award from Association TRENDS
AAM is continuing to demonstrate we’re a best-in-class trade association with a Bronze Award in “quality and creativity” from Association TRENDS, in what TRENDS calls “the most watched and respected communications contest in the association community.” AAM won for our 2017 Annual Report. Association TRENDS announced the winners of its 2018 All Media Contest at […]
Karin Hessler Joins AAM as Assistant General Counsel
WASHINGTON, DC (March 18, 2019) – Karin Hessler joins the Association for Accessible Medicines as Assistant General Counsel, effective today. “Through her extensive legal representation of manufacturers of generic and biosimilar medicines, Karin will bring valuable insights into the intellectual property barriers that our companies face in trying to deliver safe, more affordable treatment options […]
AAM Statement on Dr. Scott Gottlieb’s Departure
WASHINGTON, DC (March 5, 2019) – We wish Dr. Scott Gottlieb the very best in his next chapter. If the early news reports are true, the generic and biosimilars industry will miss this true champion of patient access. Through his generic and biosimilar action plans; education efforts about the safety and efficacy of the U.S. […]
Jonathan Kimball Joins AAM as Vice President, Trade and International Affairs
WASHINGTON DC (February 25, 2019) – Jonathan Kimball joins the Association for Accessible Medicines as Vice President, Trade and International Affairs, effective today. “Jonathan will bring a wealth of government and industry advocacy experience to an area of increasing importance to AAM and our members,” said Jeff Francer, AAM’s Senior Vice President and General Counsel. […]
AAM Announces 2019 Board of Directors
NEW ORLEANS, LA (February 4, 2019) — The Association for Accessible Medicines (AAM) announced the election of its 2019 Board of Directors and Officers today, at its 2019 Annual Meeting. Amneal President Robert Stewart will serve as the 2019 AAM Board Chairman. AAM also named Alok Sonig, CEO – US Generics and Global Head – […]
Dana Mariani Joins AAM as Director, Policy
WASHINGTON DC (September 24, 2018) – Today Dana Mariani is joining the Association for Accessible Medicines (AAM) Policy and Strategic Alliances team as Director, Policy. Prior to joining AAM, Dana was part of a cross-functional Project Management Organization team at Guidehouse (formerly the public sector arm of PwC), supporting the Centers for Medicare and Medicaid […]
AAM Announces New Regular Member and Board Member
WASHINGTON, DC (June 22, 2018) —The Association for Accessible Medicines (AAM) announced the approval of Hikma Pharmaceuticals as a Regular Member. Siggi Olafsson, CEO, will serve as Hikma’s representative on the AAM Board of Directors. Generic drugs saved the U.S. health system $253 billion in 2016, according to the Generic Drug Savings in the U.S. […]
AAM Has Adopted a Code of Business Ethics. Here’s What That Means.
The Association for Accessible Medicines (AAM) has established a new Code of Business Ethics to memorialize the ethical and business standards to which our member organizations will be held. Unanimously endorsed by our Board of Directors, the code takes effect on September 1. Is there anything surprising in the Code? No and yes. Nothing in the […]
Tara Ryan Joins AAM as Vice President, State Government Affairs
WASHINGTON DC (May 14, 2018) – Tara Ryan joins the Association for Accessible Medicines’ (AAM) State Government Affairs team as Vice President, State Government Affairs, effective today. She reports to Chris Bowlin, Senior Vice President, Government Affairs. “Tara joins the generics industry at a time when the challenges to patient access from misguided legislation in […]
Recap of Access! 2018 — Chip’s Call to Action (Part 2)
Access! 2018 emphasized the power that member companies have when they work together for advocacy. “We are the underdogs,” President and CEO Chip Davis declared in his remarks. In the face of massive buyer consortiums and brand-name pharmaceutical manufacturers with far greater financial resources than AAM and its members as well as state and federal […]
AAM Announces 2018 Board of Directors
ORLANDO, FL (February 12, 2018) —The Association for Accessible Medicines (AAM) announced the election of its 2018 Board of Directors and Executive Committee today, at its 2018 Annual Meeting. Apotex President and Chief Operating Officer Jeff Watson is the 2018 AAM Chair of the Board. AAM also named Robert Stewart, President, Amneal, as Vice-Chairman of […]
AAM Continues to Build Its State Government Affairs Team
WASHINGTON DC (NOVEMBER 6, 2017) – Brett Michelin and Ashlie Van Meter are joining the Association for Accessible Medicines’ (AAM) State Government Affairs team as Director and Senior Director, respectively. “We are excited to welcome Ashlie and Brett to the AAM team,” says Carrie Hartgen, Vice President, State Government Affairs. “The depth and breadth of their […]
